In vitro study of polyoxyethylene alkyl ether niosornes for delivery of insulin

被引:215
作者
Pardakhty, Abbas
Varshosaz, Jaleh
Rouholamini, Abdolhossein
机构
[1] Kerman Univ Med Sci, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut, Kerman, Iran
[2] Isfahan Univ Med Sci, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut, Esfahan, Iran
[3] Univ Tehran Med Sci, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut, Tehran, Iran
关键词
insulin; niosomes; oral delivery; polyoxyethylene alkyl ethers; proteolytic enzymes;
D O I
10.1016/j.ijpharm.2006.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, mosomes of polyoxyethylene alkyl ethers (Brij (TM)) were prepared for encapsulation of insulin by film hydration method. Without cholesterol, brij 35 and brij 58 did not form niosomes, apparently because of relatively large polar head groups in comparison with their alkyl chains. The size of vesicles depended on the cholesterol content, charge incorporation or hydrophilicity of surfactants. Entrapment of insulin in bilayer structure of mosomes protected it against proteolytic activity of a-chymotrypsin, trypsin and pepsin in vitro. The maximum protection activity was seen in brij 92/cholesterol (7:3 molar ratios) in which only 26.3 +/- 3.98% of entrapped insulin was released during 24 h in simulated intestinal fluid (SIF). The kinetic of drug release for most formulations could be best described by Baker and Lonsdale equation indicating diffusion based delivery mechanism. These results indicate that niosomes could be developed as sustained release oral dosage forms for delivery of peptides and proteins such as insulin. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:130 / 141
页数:12
相关论文
共 60 条
[1]   Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol [J].
Agarwal, R ;
Katare, OP ;
Vyas, SP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 228 (1-2) :43-52
[2]   Preparation and in vitro in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical tubular niosomes [J].
Arunothayanun, P ;
Turton, JA ;
Uchegbu, IF ;
Florence, AT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (01) :34-38
[3]  
AUSBORN M, 1992, EUR J PHARM BIOPHARM, V38, P133
[4]   THE PREPARATION AND PROPERTIES OF NIOSOMES NON-IONIC SURFACTANT VESICLES [J].
BAILLIE, AJ ;
FLORENCE, AT ;
HUME, LR ;
MUIRHEAD, GT ;
ROGERSON, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (12) :863-868
[5]  
Baker R. W., 1974, Controlled Release of Biologically Active Agents, P15
[6]  
Bouwstra J.A., 1996, COLLOIDAL DRUG DELIV, P191
[7]  
Brewer JM, 1998, J IMMUNOL, V161, P4000
[8]  
BREWER JM, 1992, IMMUNOLOGY, V75, P570
[9]  
CABLE C, 1989, THESIS U STRATHCLYDE
[10]   Development and in vivo evaluation of an oral insulin-PEG delivery system [J].
Calceti, P ;
Salmaso, S ;
Walker, G ;
Bernkop-Schnürch, A .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 22 (04) :315-323